Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease (Review)

R. Caslake, A. Macleod, Natalie Ives, Rebecca Stowe, Carl Counsell*

*Corresponding author for this work

Research output: Contribution to journalReview article

8 Citations (Scopus)

Fingerprint Dive into the research topics of 'Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease (Review)'. Together they form a unique fingerprint.

Medicine & Life Sciences